Back to School: How biopharma can reboot drug development. Access exclusive analysis here

1016 Menlo Ventures
BioCentury & Getty Images

Finance

Menlo to continue healthcare push at intersection of tech, life sciences with $500M fund

Menlo Ventures’ new fund signals that life sciences again a core focus for the firm

Menlo Ventures’ new fund signals that life sciences is again a core focus for the firm.

Read the full 549 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE